During the past decade, Finsen Centre conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Finsen Centre" are "Solid Tumors Harboring NTRK Fusion" (2 trials), "Non Small Cell Lung Cancer" (1 trials), "Prostate Cancer" (1 trials), "Renal Cell Carcinoma" (1 trials) and "Solid Tumor" (1 trials). Many other conditions were trialed in "Finsen Centre" in a lesser frequency.

Most popular intervention types in "Finsen Centre" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (1 trials), "Abiraterone Acetate" (1 trials), "BAY2757556 (Larotrectinib, Vitrakvi)" (1 trials), "LY3300054" (1 trials) and "LY3381916" (1 trials). Other intervention names were less common.

The vast majority of trials in "Finsen Centre" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Finsen Centre". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Finsen Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Finsen Centre, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".